Cardiovascular Risk Factor Burden and Treatment Control in Patients with Chronic Kidney Disease: A Cross-Sectional Study.

Autor:	Kitamura H; Department of Medicine and Clinical Science, Graduate School of Medical Sciences., Tanaka S; Department of Medicine and Clinical Science, Graduate School of Medical Sciences., Hiyamuta H; Department of Internal Medicine, Faculty of Medicine, Division of Nephrology and Rheumatology, Fukuoka University., Shimamoto S; Department of Medicine and Clinical Science, Graduate School of Medical Sciences., Tsuruya K; Department of Nephrology, Nara Medical University., Nakano T; Department of Medicine and Clinical Science, Graduate School of Medical Sciences., Kitazono T; Department of Medicine and Clinical Science, Graduate School of Medical Sciences.
Jazyk:	angličtina
Zdroj:	Journal of atherosclerosis and thrombosis [J Atheroscler Thromb] 2023 Sep 01; Vol. 30 (9), pp. 1210-1288. Date of Electronic Publication: 2022 Dec 29.
DOI:	10.5551/jat.63891
Abstrakt:	Aim: Cardiovascular disease is a life-threatening chronic kidney disease (CKD) complication. Although cardiovascular risk factor management is significant in patients with CKD, there are few reports that detail the frequency of complications and the treatment of cardiovascular risk factors at different stages of CKD in clinical practice. Methods: There were a total of 3,407 patients with non-dialysis-dependent CKD who participated in the Fukuoka Kidney disease Registry Study, and they were cross-sectionally analyzed. The patients were classified into five groups based on their estimated glomerular filtration rate and urinary albumin to creatinine ratio according to Kidney Disease: Improving Global Outcomes 2012 guidelines, which recommend low, moderate, high, very high, and extremely high risk groups. The primary outcomes were the cardiovascular risk factor burden and the treatment status of cardiovascular risk factors. Using a logistic regression model, the association between the CKD groups and the treatment status of each risk factor was examined. Results: The proportion of patients with hypertension, diabetes mellitus, and dyslipidemia significantly increased as CKD progressed, whereas the proportion of patients who achieved cardiovascular risk factor treatment targets significantly decreased. In the multivariable analysis, the odds ratios (ORs) of uncontrolled treatment targets were significantly higher for hypertension (OR 3.68) in the extremely high risk group than in the low risk group. Conclusions: Patients with non-dialysis-dependent CKD demonstrate an increased cardiovascular risk factor burden with greater severity of CKD. Extremely high risk CKD is associated with difficulty in managing hypertension.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu